WuXi AppTec Co., Ltd. (WUXAY)

OTCMKTS · Delayed Price · Currency is USD
15.69
+1.03 (6.99%)
At close: Feb 27, 2026
97.41%
Market Cap 42.83B
Revenue (ttm) 6.16B
Net Income (ttm) 2.11B
Shares Out n/a
EPS (ttm) 0.65
PE Ratio 20.34
Forward PE 18.42
Dividend 0.18 (1.10%)
Ex-Dividend Date Sep 9, 2025
Volume 340
Average Volume 2,844
Open 15.69
Previous Close 14.67
Day's Range 15.69 - 15.69
52-Week Range 5.73 - 16.35
Beta 0.62
RSI 55.85
Earnings Date Mar 24, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 37,832
Stock Exchange OTCMKTS
Ticker Symbol WUXAY
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.